ds-8273a
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT02076451)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
WDR5 agonist
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594356 ↗
Also known as
- ds-8273a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02991196 | Phase 1 | Dec 1, 2016 | Bristol-Myers Squibb, Daiichi Sankyo |
| NCT02983006 | Phase 1 | Oct 1, 2016 | Bristol-Myers Squibb, Daiichi Sankyo, New York University |
| NCT02076451 | Phase 1 | Feb 1, 2014 | Daiichi Sankyo |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daiichi Sankyo | For profit | 3 | 2 | 1 | 2014 |
| Bristol-Myers Squibb | For profit | 2 | 0 | 1 | 2016 |
| New York University | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1